Crespine Gel in Trinidad & Tobago
Crespine Gel is an injectable cross-linked hyaluronic acid gel implant for the treatment of osteoarthritis joint pain. A physician administers it as a single 2 ml intra-articular injection — many other hyaluronic acid preparations require three to five weekly appointments.
Supply routes differ between countries. Use the form below and we will tell you how Crespine Gel can be obtained in Trinidad & Tobago, or put you in touch with the right contact there.
Regulatory status
Trinidad & Tobago lies outside the EU and EEA, so national registration rules apply alongside the CE mark. Registration status differs by country and changes over time — please contact us for the current position in Trinidad & Tobago before planning treatment or supply.
Manufactured by BioPolymer GmbH & Co. KG, Dümmer, Germany. Class III medical device. Quality management certified to ISO 13485:2016, certificate 145211-23-12-15. On the market since 2009.
Two variants
-
Crespine® Gel
Standard variant, without local anaesthetic.
-
Crespine® Gel +
Additionally contains the local anaesthetic prilocaine, released slowly from the hyaluronic acid matrix.
Which variant is appropriate is decided by the treating physician. Crespine Gel is not supplied directly to private individuals.
Send an enquiry
Contact us if you would like to obtain Crespine Gel in Trinidad & Tobago or find a treating physician. We will get back to you.